Axa’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-222,600
| Closed | -$2.62M | – | 1384 |
|
|
2019
Q2 | $2.62M | Buy |
222,600
+139,900
| +169% | +$1.65M | 0.01% | 802 |
|
|
2019
Q1 | $1.13M | Buy |
82,700
+18,700
| +29% | +$255K | ﹤0.01% | 956 |
|
|
2018
Q4 | $656K | Buy |
+64,000
| New | +$656K | ﹤0.01% | 1043 |
|
|
2018
Q3 | – | Sell |
-19,700
| Closed | -$311K | – | 1420 |
|
|
2018
Q2 | $311K | Sell |
19,700
-538,209
| -96% | -$8.5M | ﹤0.01% | 1222 |
|
|
2018
Q1 | $7.09M | Sell |
557,909
-529,300
| -49% | -$6.72M | 0.03% | 552 |
|
|
2017
Q4 | $12.4M | Buy |
1,087,209
+95,126
| +10% | +$1.09M | 0.05% | 396 |
|
|
2017
Q3 | $12.2M | Buy |
992,083
+661,253
| +200% | +$8.1M | 0.05% | 385 |
|
|
2017
Q2 | $3.79M | Sell |
330,830
-12,363
| -4% | -$142K | 0.02% | 666 |
|
|
2017
Q1 | $7.14M | Buy |
343,193
+76,435
| +29% | +$1.59M | 0.03% | 515 |
|
|
2016
Q4 | $5.55M | Buy |
266,758
+5,068
| +2% | +$105K | 0.03% | 548 |
|
|
2016
Q3 | $8.58M | Sell |
261,690
-24,930
| -9% | -$817K | 0.04% | 444 |
|
|
2016
Q2 | $7.16M | Buy |
286,620
+33,441
| +13% | +$835K | 0.03% | 480 |
|
|
2016
Q1 | $6.2M | Sell |
253,179
-4,090
| -2% | -$100K | 0.03% | 500 |
|
|
2015
Q4 | $8.5M | Buy |
257,269
+12,760
| +5% | +$421K | 0.04% | 431 |
|
|
2015
Q3 | $8.01M | Buy |
244,509
+55,074
| +29% | +$1.8M | 0.03% | 438 |
|
|
2015
Q2 | $10M | Buy |
+189,435
| New | +$10M | 0.04% | 419 |
|